SPECIAL EDITION RELEASE: RARE BLOG! In this feature of our RARE series, host Laura Hulley speaks with Ulf Staginnus, an international leader in Market Access, Pricing and Health Economics. Ulf shares insights from nearly 30 years in biotech and pharma, discussing European HTA requirements, pricing frameworks, and what it really takes for companies to successfully bring orphan and innovative medicines to patients across Europe. Read the full discussion here: https://lnkd.in/dq52E98b #RareDisease #MarketAccess #Biotech #OrphanDrugs
